Table 4.
Variable | SCC
|
BCC
|
||
---|---|---|---|---|
HR (95% CI) | P Valuea | HR (95% CI) | P Valuea | |
Posttransplantb | ||||
Azathioprine use | 0.93 (0.54–1.59) | .79 | 0.55 (0.31–0.97) | .03 |
Mycophenolate mofetil use | 1.05 (0.57–1.94) | .86 | 2.74 (1.50–5.04) | .001 |
HSV infection | 2.90 (1.24–6.77) | .01 | 3.38 (1.32–8.66) | .01 |
Nonskin cancer | 1.80 (1.09–2.99) | .02 | 1.31 (0.70–2.43) | .40 |
HLA mismatches (≥1 vs 0) | 0.53 (0.28–0.98) | .04 | 0.72 (0.36–1.45) | .36 |
Abbreviations: CI, confidence interval; HR, hazard ratio; HSV, herpes simplex virus.
P ≤ .05 was considered to be statistically significant.
Variables measured after transplant are time-dependent predictors.